mynth
03/2019

RESIDALYA acquired by DOMUSVI

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV 100M - 350M EUR

Context

DomusVi entered into exclusive negotiations to acquire 100% of the capital of Residalya, in a move designed to significantly densify its territorial coverage within France. The transaction allowed DomusVi to absorb 35 additional facilities and roughly 2,630 beds, bringing its total capacity to over 17,000 beds and narrowing the gap with its primary market competitors. This strategic build-up was motivated by the need to reach a critical industrial scale, merging Residalya’s localized expertise and specialized assets—including the ownership of twelve of its residences—into DomusVi’s global operational platform.

RESIDALYA, which reported an EBITDA margin of in 2016, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Residalya functions as a significant operator in the French elderly care market, managing a nationwide network of 35 facilities that include both medicalized nursing homes and autonomous senior residences. Prior to its acquisition, the company controlled approximately 2,630 beds and maintained a strong regional presence, particularly in the Nouvelle-Aquitaine and Provence-Alpes-Côte d'Azur regions.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2016
2015

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
07/2019NAXICAP PARTNERS / ARDIANEMERAFRANCENursing Homes
04/2019COLISÉEARMONEABELGIUMNursing Homes
01/2019HUMANACORONARIA HOIVAFINLANDNursing Homes
04/2018INVESTINDUSTRIALLIFEBRAINITALYLabs (Biology)
03/2018THE ADOLFSEN GROUPFRÖSUNDASWEDENHealthcare Facilities
03/2018ICV PARTNERSOUTPATIENT IMAGING AFFILIATESUNITED STATESRadiology
01/2018PERMIRAI-MED RADIOLOGY NETWORKAUSTRALIARadiology
06/2017ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
04/2017EQT PARTNERSCOLISÉEFRANCENursing Homes
01/2017PARTNERS GROUP / PSP INVESTMENTSCERBA HEALTHCAREFRANCELabs (Biology)

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of RESIDALYA by DOMUSVI are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: residalya